MERCHIERS; Pascal
Patent Applications and Registrations
Patent applications and USPTO patent grants for MERCHIERS; Pascal.The latest application filed is for "cd38 antibody".
- MERCHIERS; Pascal - Stevenage Hertfordshire GB
- Merchiers; Pascal - Stevenage GB
- Merchiers; Pascal - Hertfordshire GB
- MERCHIERS; Pascal - Kasterlee BE
- MERCHIERS; Pascal - Welwyn Garden City GB
| Patent | Date |
|---|---|
| Cd38 Antibody App 20220135697 - GOUBIER; Anne ; et al. | 2022-05-05 |
| CD38 antibody Grant 11,236,173 - Goubier , et al. February 1, 2 | 2022-02-01 |
| Cd38 Modulating Antibody Agents App 20210277138 - Merchiers; Pascal ; et al. | 2021-09-09 |
| Anti-cd25 Antibody Agents App 20210054084 - Goubier; Anne ; et al. | 2021-02-25 |
| Anti-cd25 For Tumour Specific Cell Depletion App 20210047420 - Goubier; Anne ; et al. | 2021-02-18 |
| Anti-cd25 For Tumour Specific Cell Depletion App 20210040221 - Goubier; Anne ; et al. | 2021-02-11 |
| Anti-cd25 For Tumour Specific Cell Depletion App 20210009704 - Goubier; Anne ; et al. | 2021-01-14 |
| Anti-cd25 Antibody Agents App 20210009699 - Goubier; Anne ; et al. | 2021-01-14 |
| Anti-cd25 For Tumour Specific Cell Depletion App 20210009703 - Goubier; Anne ; et al. | 2021-01-14 |
| Anti-cd25 For Tumour Specific Cell Depletion App 20210009702 - Goubier; Anne ; et al. | 2021-01-14 |
| Anti-cd25 Antibody Agents App 20200407454 - Goubier; Anne ; et al. | 2020-12-31 |
| Cd38 Modulating Antibody App 20200362049 - GOUBIER; Anne ; et al. | 2020-11-19 |
| Cd38 Antibody App 20200362050 - GOUBIER; Anne ; et al. | 2020-11-19 |
| Vegf-binding Molecules App 20200308267 - GSCHWIND; Andreas ; et al. | 2020-10-01 |
| Compounds And Methods For Tumour-specific Cell Depletion App 20200283535 - MERCHIERS; Pascal ; et al. | 2020-09-10 |
| Anti-CD25 antibody agents Grant 10,752,691 - Goubier , et al. A | 2020-08-25 |
| Anti-CD25 antibody agents Grant 10,745,485 - Goubier , et al. A | 2020-08-18 |
| Anti-CD25 antibody agents Grant 10,738,125 - Goubier , et al. A | 2020-08-11 |
| Ang2-binding Molecules App 20200207845 - Ott; Rene Georg ; et al. | 2020-07-02 |
| Cd38 Modulating Antibody App 20200190209 - Merchiers; Pascal ; et al. | 2020-06-18 |
| Fc-optimized Anti-cd25 For Tumor Specific Cell Depletion App 20200010554 - Goubier; Anne ; et al. | 2020-01-09 |
| Anti-cd25 Antibody Agents App 20190322752 - Goubier; Anne ; et al. | 2019-10-24 |
| Anti-cd25 Antibody Agents App 20190284287 - Goubier; Anne ; et al. | 2019-09-19 |
| Ang2-binding Molecules App 20190135907 - Ott; Rene Georg ; et al. | 2019-05-09 |
| Vegf-binding Molecules App 20180201671 - GSCHWIND; Andreas ; et al. | 2018-07-19 |
| Ang2-binding Molecules App 20170107281 - OTT; Rene Georg ; et al. | 2017-04-20 |
| Vegf-binding Molecules App 20160200806 - GSCHWIND; Andreas ; et al. | 2016-07-14 |
| Bispecific Binding Molecules For Anti-angiogenesis Therapy App 20140120095 - BORGES; Eric ; et al. | 2014-05-01 |
| A-beta Binding Polypeptides App 20140030275 - PARK; John E. ; et al. | 2014-01-30 |
| Nucleic acid molecules encoding A-beta binding polypeptides Grant 8,614,308 - Park , et al. December 24, 2 | 2013-12-24 |
| Ang2-binding Molecules App 20130259859 - OTT; Rene Georg ; et al. | 2013-10-03 |
| A-beta Binding Polypeptides App 20130017209 - PARK; John E. ; et al. | 2013-01-17 |
| A-beta binding polypeptides Grant 8,337,845 - Park , et al. December 25, 2 | 2012-12-25 |
| Vegf-binding Molecules App 20120225081 - GSCHWIND; Andreas ; et al. | 2012-09-06 |
| A-beta Binding Polypeptides App 20120058118 - PARK; John E. ; et al. | 2012-03-08 |
| Dll4-binging Molecules App 20110195494 - BORGES; Eric ; et al. | 2011-08-11 |
| Bispecific Binding Molecules For Anti-angiogenesis Therapy App 20110172398 - BORGES; Eric ; et al. | 2011-07-14 |
| Nanobodies Tm Against Amyloid-Beta and Polypeptides Comprising the Same for the Treatment of Degenerative Neural Diseases Such as Alzheimer's Disease App 20080107601 - Lauwereys; Marc ; et al. | 2008-05-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 